- Home
- UBSI vs GRFS Comparison
UBSI vs GRFS Comparison
Compare UBSI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBSI
- GRFS
- Stock Information
- Founded
- UBSI 1982
- GRFS 1940
- Country
- UBSI United States
- GRFS Spain
- Employees
- UBSI N/A
- GRFS N/A
- Industry
- UBSI Major Banks
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- UBSI Finance
- GRFS Health Care
- Exchange
- UBSI Nasdaq
- GRFS Nasdaq
- Market Cap
- UBSI 5.1B
- GRFS 5.9B
- IPO Year
- UBSI N/A
- GRFS 2006
- Fundamental
- Price
- UBSI $36.66
- GRFS $8.78
- Analyst Decision
- UBSI Hold
- GRFS Hold
- Analyst Count
- UBSI 3
- GRFS 1
- Target Price
- UBSI $41.83
- GRFS $10.30
- AVG Volume (30 Days)
- UBSI 746.5K
- GRFS 753.5K
- Earning Date
- UBSI 10-23-2025
- GRFS 01-01-0001
- Dividend Yield
- UBSI 4.01%
- GRFS 1.61%
- EPS Growth
- UBSI 15.26
- GRFS N/A
- EPS
- UBSI 3.05
- GRFS 0.64
- Revenue
- UBSI $1,127,073,000.00
- GRFS $8,821,017,248.00
- Revenue This Year
- UBSI $23.91
- GRFS $5.31
- Revenue Next Year
- UBSI $4.64
- GRFS $6.02
- P/E Ratio
- UBSI $12.08
- GRFS $17.40
- Revenue Growth
- UBSI 11.50
- GRFS 7.31
- 52 Week Low
- UBSI $30.51
- GRFS $6.19
- 52 Week High
- UBSI $44.43
- GRFS $11.14
- Technical
- Relative Strength Index (RSI)
- UBSI 53.43
- GRFS 38.95
- Support Level
- UBSI $35.95
- GRFS $8.21
- Resistance Level
- UBSI $36.69
- GRFS $9.90
- Average True Range (ATR)
- UBSI 0.70
- GRFS 0.31
- MACD
- UBSI 0.15
- GRFS -0.05
- Stochastic Oscillator
- UBSI 71.03
- GRFS 34.02
About UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services.
About GRFS Grifols S.A.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.